A membrane topology model for human interferon inducible transmembrane protein 1

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Weston, Stuart ^a   Czieso, Stephanie ^a   White, Ian J ^a   Smith, Sarah E ^b   Kellam, Paul ^a,b   Marsh, Mark ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; INTERFERON INDUCIBLE TRANSMEMBRANE PROTEIN 1; MEMBRANE PROTEIN; PROTEINASE; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN; LEU-13 ANTIGEN; PRIMER DNA;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LABELING; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; ENZYME DEGRADATION; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE MICROSCOPY; PROTEIN ANALYSIS; PROTEIN INDUCTION; PROTEIN STRUCTURE; CHEMICAL STRUCTURE; CHEMISTRY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HEK293 CELL LINE; IMAGE PROCESSING; PROTEIN CONFORMATION; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; ULTRASTRUCTURE; WESTERN BLOTTING;

ANTIGENS, DIFFERENTIATION; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA PRIMERS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELLS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, MOLECULAR; PROTEIN CONFORMATION; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84905661555     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104341     Document Type: Article

References (29)

1. Brass AL, Huang I-C, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254. doi:10.1016/j.cell.2009.12.017.
2. Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR (1984) Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38: 745-755. (Pubitemid 15176105)
3. Lewin AR, Reid LE, McMahon M, Stark GR, Kerr IM (1991) Molecular analysis of a human interferon-inducible gene family. Eur J Biochem 199: 417-423.
4. Bailey CC, Huang I-C, Kam C, Farzan M (2012) Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog 8: e1002909. doi:10.1371/journal.-ppat. 1002909.
5. Everitt AR, Clare S, Pertel T, John SP, Wash RS, et al. (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484: 519-523. doi:10.1038/nature10921.
6. Smith SE, Weston S, Kellam P, Marsh M (2014) IFITM proteins - cellular inhibitors of viral entry. Curr Opin Virol 4: 71-77.
7. Zhao X, Guo F, Liu F, Cuconati A, Chang J, et al. (2014) Interferon induction of IFITM proteins promotes infection by human coronavirus OC43. Proc Natl Acad Sci U S A: 1-6. doi:10.1073/pnas.1320856111.
8. Warren CJ, Griffin LM, Little AS, Huang I-C, Farzan M, et al. (2014) The Antiviral Restriction Factors IFITM1, 2 and 3 Do Not Inhibit Infection of Human Papillomavirus, Cytomegalovirus and Adenovirus. PLoS One 9: e96579. doi:10.1371/journal.pone.0096579.
9. Feeley EM, Sims JS, John SP, Chin CR, Pertel T, et al. (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7: e1002337. doi:10.1371/journal.ppat.1002337.
10. Jia R, Pan Q, Ding S, Rong L, Liu S (2012) The N-Terminal Region of IFITM3 Modulates Its Antiviral Activity by Regulating IFITM3 Cellular Localization. J Virol 86: 13697-13707. doi:10.1128/JVI.01828-12.
11. Li K, Markosyan RM, Zheng Y-M, Golfetto O, Bungart B, et al. (2013) IFITM Proteins Restrict Viral Membrane Hemifusion. PLoS Pathog 9: e1003124. doi:10.1371/journal.ppat.1003124.
12. Amini-Bavil-Olyaee S, Choi YJ, Lee JH, Shi M, Huang I, et al. (2013) The Antiviral Effector IFITM3 Disrupts Intracellular Cholesterol Homeostasis to Block Viral Entry. Cell Host Microbe: 452-464.
13. Lin T-Y, Chin CR, Everitt AR, Clare S, Perreira JM, et al. (2013) Amphotericin B Increases Influenza A Virus Infection by Preventing IFITM3-Mediated Restriction. Cell Rep 5: 895-908. doi:10.1016/j.celrep.2013.10. 033.
14. Desai TM, Marin M, Chin CR, Savidis G, Brass AL, et al. (2014) IFITM3 Restricts Influenza A Virus Entry by Blocking the Formation of Fusion Pores following Virus-Endosome Hemifusion. PLoS Pathog 10: e1004048. doi:10.1371/journal.ppat.1004048.
15. Chen YX, Welte K, Gebhard DH, Evans RL (1984) Induction of T cell aggregation by antibody to a 16kd human leukocyte surface antigen. J Immunol 133: 2496-2501. (Pubitemid 15204774)
16. Yount JS, Moltedo B, Yang Y-Y, Charron G, Moran TM, et al. (2010) Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol 6: 610-614. doi:10.1038/nchembio.405.
17. Evans SS, Lee DB, Han T, Tomasi TB, Evans RL (1990) Monoclonal antibody to the interferon-inducible protein Leu-13 triggers aggregation and inhibits proliferation of leukemic B cells. Blood 76: 2583-2593.
18. Takahashi S, Doss C, Levy S, Levy R (1990) TAPA-1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu-13 antigen. J Immunol 145: 2207-2213. (Pubitemid 20343386)
19. Yount JS, Karssemeijer RA, Hang HC (2012) S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J Biol Chem 287: 19631-19641. doi:10.1074/jbc.M112.362095.
20. Hach JC, McMichael T, Chesarino NM, Yount JS (2013) Palmitoylation on conserved and nonconserved cysteines of murine IFITM1 regulates its stability and anti-influenza A virus activity. J Virol 87: 9923-9927. doi:10.1128/JVI. 00621-13.
21. Bailey CC, Kondur HR, Huang I-C, Farzan M (2013) Interferon-Induced Transmembrane Protein 3 is a Type II Transmembrane Protein. J Biol Chem. doi:10.1074/jbc.M113.514356.
22. Jia R, Xu F, Qian J, Yao Y, Miao C, et al. (2014) Identification of an endocytic signal essential for the antiviral action of IFITM3. Cell Microbiol: n/a-n/a. doi:10.1111/cmi.12262.
23. Smith SE, Gibson MS, Wash RS, Ferrara F, Wright E, et al. (2013) Chicken IFITM3 restricts Influenza viruses and Lyssaviruses in vitro. J Virol. doi:10.1128/JVI.01443-13.
24. Bolte S, Cordelières FP (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224: 213-232. doi:10.1111/j.1365-2818.2006.01706.x. (Pubitemid 46010930)
25. Slot JW, Geuze HJ, Gigengack S, Lienhard GE, James DE (1991) Immunolocalization of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J Cell Biol 113: 123-135. (Pubitemid 21909679)
26. Deneka M, Pelchen-Matthews A, Byland R, Ruiz-Mateos E, Marsh M (2007) In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J Cell Biol 177: 329-341. doi:10.1083/jcb.200609050. (Pubitemid 46658643)
27. Jia R, Pan Q, Ding S, Rong L, Liu S-L, et al. (2012) The N-Terminal Region of IFITM3 Modulates Its Antiviral Activity by Regulating IFITM3 Cellular Localization. J Virol 86: 13697-13707. doi:10.1128/JVI.01828-12.
28. Huang I, Bailey C, Weyer J, Radoshitzky S, Becker M, et al. (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLos Pathog 7: e1001258.
29. John SP, Chin CR, Perreira J, Feeley EM, Aker A, et al. (2013) The CD225 Domain of IFITM3 is Required for both IFITM Protein Association and Inhibition of Influenza A Virus and Dengue Virus Replication. J Virol. doi:10.1128/JVI. 00481-13.